Keryx Biopharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
| Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc. |
| Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited |
| 1:2023cv00331 |
| March 24, 2023 |
| US District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 11, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #11 MOTION for Extension of Time to Respond to Complaint (Unopposed) filed by Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 4/11/23. (ntl)
|
| Filing 11 MOTION for Extension of Time to Respond to Complaint (Unopposed) - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Raucci, Anthony) |
| Filing 10 WAIVER OF SERVICE returned executed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.: For Zydus Worldwide DMCC waiver sent on 3/28/2023, answer due 5/30/2023. (Raucci, Anthony) |
| Filing 9 WAIVER OF SERVICE returned executed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 3/28/2023, answer due 5/30/2023. (Raucci, Anthony) |
| Filing 8 WAIVER OF SERVICE returned executed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.: For Zydus Lifesciences Limited waiver sent on 3/28/2023, answer due 5/30/2023. (Raucci, Anthony) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (nms) |
| Remark: MDL Panel has been notified of case opening. (mpb) |
| Filing 7 Summons Issued as to Zydus Lifesciences Limited on 3/24/2023; Zydus Pharmaceuticals (USA) Inc. on 3/24/2023; Zydus Worldwide DMCC on 3/24/2023. (Attachments: #1 Summons Issued, #2 Summons Issued)(mpb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Panion & BF Biotech, Inc.. (mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Akebia Therapeutics, Inc. for Keryx Biopharmaceuticals, Inc. filed by Keryx Biopharmaceuticals, Inc.. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/10/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/10/2025. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC ( Filing fee $ 402, receipt number ADEDC-4097120.) - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Attachments: #1 Exhibits A-N, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
